Perturbed replication induced genome wide or at common fragile sites is differently managed in the absence of WRN

Carcinogenesis

Volumn 33, Issue 9, 2012, Pages 1655-1663

  Murfuni, Ivana ^a   De Santis, Anita ^a   Federico, Maurizio ^a   Bignami, Margherita ^a   Pichierri, Pietro ^a   Franchitto, Annapaola ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; EXONUCLEASE; HELICASE; RAD51 PROTEIN; SINGLE STRANDED DNA; WERNER SYNDROME PROTEIN;

ARTICLE; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CHROMOSOME REPLICATION; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; GENE; GENE REPLICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WESTERN BLOTTING; WRN GENE;

CELLS, CULTURED; CHROMOSOME FRAGILE SITES; DNA; DNA BREAKS, DOUBLE-STRANDED; DNA REPLICATION; DNA-BINDING PROTEINS; ENDONUCLEASES; EXODEOXYRIBONUCLEASES; GENOME, HUMAN; HUMANS; RAD51 RECOMBINASE; RECQ HELICASES;

EID: 84865564579     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs206     Document Type: Article

References (52)

1. Goto, M. et al. (1996) Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol. Biomarkers Prev., 5, 239-46.
2. Hrabko, R.P. et al. (1982) Werner's syndrome with associated malignant neoplasms. Arch. Dermatol., 118, 106-8.
3. Martin, G.M. et al. (2000) Lessons from human progeroid syndromes. Nature, 408, 263-6.
4. Oshima, J. (2000) The Werner syndrome protein: an update. Bioessays, 22, 894-901.
5. Salk, D. (1985) In vitro studies of Werner syndrome cells: aberrant growth and chromosome behavior. Basic Life Sci., 35, 419-26.
6. Fukuchi, K. et al. (1989) Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc. Natl. Acad. Sci. U.S.A., 86, 5893-7.
7. Gebhart, E. et al. (1988) Spontaneous and induced chromosomal instability in Werner syndrome. Hum. Genet., 80, 135-9.
8. Moser, M.J. et al. (2000) Genetic instability and hematologic disease risk in Werner syndrome patients and heterozygotes. Cancer Res., 60, 2492-6.
9. van Brabant, A.J. et al. (2000) DNA helicases, genomic instability, and human genetic disease. Annu. Rev. Genomics Hum. Genet., 1, 409-59.
10. Lebel, M. et al. (1998) A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc. Natl. Acad. Sci. U.S.A., 95, 13097-102.
11. Pichierri, P. et al. (2000) Werner's syndrome cell lines are hypersensitive to camptothecin-induced chromosomal damage. Mutat. Res., 456, 45-57.
12. Pichierri, P. et al. (2001) Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol. Biol. Cell, 12, 2412-21.
13. Pirzio, L.M. et al. (2008) Werner syndrome helicase activity is essential in maintaining fragile site stability. J. Cell Biol., 180, 305-14.
14. Poot, M. et al. (2001) Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J., 15, 1224-6.
15. Khakhar, R.R. et al. (2003) RecQ helicases: multiple roles in genome maintenance. Trends Cell Biol., 13, 493-501.
16. Saintigny, Y. et al. (2002) Homologous recombination resolution defect in werner syndrome. Mol. Cell. Biol., 22, 6971-8.
17. Ammazzalorso, F. et al. (2010) ATR and ATM differently regulate WRN to prevent DSBs at stalled replication forks and promote replication fork recovery. EMBO J., 29, 3156-69.
18. Opresko, P.L. et al. (2004) The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol. Cell, 14, 763-74.
19. Shen, J.C. et al. (2000) Werner syndrome exonuclease catalyzes structure-dependent degradation of DNA. Nucleic Acids Res., 28, 3260-8.
20. Chen, L. et al. (2003) WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair. Aging Cell, 2, 191-9.
21. Opresko, P.L. et al. (2009) The Werner syndrome helicase/exonuclease processes mobile D-loops through branch migration and degradation. PLoS ONE, 4, e4825.
22. Swanson, C. et al. (2004) The Werner syndrome protein has separable recombination and survival functions. DNA Repair (Amst.), 3, 475-82.
23. Bai, Y. et al. (2003) Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein. Hum. Genet., 113, 337-47.
24. Cheng, W.H. et al. (2004) Linkage between Werner syndrome protein and the Mre11 complex via Nbs1. J. Biol. Chem., 279, 21169-76.
25. Franchitto, A. et al. (2008) Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway. J. Cell Biol., 183, 241-52.
26. Murfuni, I., et al. (2012) The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation. Oncogene, Mar 12. doi: 10.1038/onc.2012.80. [Epub ahead of print]
27. Boddy, M.N. et al. (2000) Damage tolerance protein Mus81 associates with the FHA1domain of checkpoint kinase Cds1. Mol. Cell. Biol., 20, 8758-66.
28. Kaliraman, V. et al. (2001) Functional overlap between Sgs1-Top3 and the Mms4-Mus81 endonuclease. Genes Dev., 15, 2730-40.
29. Mullen, J.R. et al. (2001) Requirement for three novel protein complexes in the absence of the Sgs1 DNA helicase in Saccharomyces cerevisiae. Genetics, 157, 103-18.
30. Friedrich, K. et al. (2010) WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations. Hum. Genet., 128, 103-11.
31. Olive, P.L. et al. (1991) DNA double-strand breaks measured in individual cells subjected to gel electrophoresis. Cancer Res., 51, 4671-76.
32. Fabre, F. et al. (2002) Alternate pathways involving Sgs1/Top3, Mus81/ Mms4, and Srs2 prevent formation of toxic recombination intermediates from single-stranded gaps created by DNA replication. Proc. Natl. Acad. Sci. U.S.A., 99, 16887-92.
33. Pichierri, P., et al. (2011) The RAD9-RAD1-HUS1 (9.1.1) complex interacts with WRN and is crucial to regulate its response to replication fork stalling. Oncogene, Oct 17. doi: 10.1038/onc.2011.468. [Epub ahead of print]
34. Constantinou, A. et al. (2000) Werner's syndrome protein (WRN) migrates Holliday junctionsand co-localizes with RPA upon replication arrest. EMBO Rep., 1, 80-4.
35. Hashimoto, Y. et al. (2010) Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. Nat. Struct. Mol. Biol., 17, 1305-311.
36. Baynton, K. et al. (2003) WRN interacts physically and functionally with the recombination mediator protein RAD52. J. Biol. Chem., 278, 36476-86.
37. Rodríguez-López, A.M. et al. (2002) Asymmetry of DNA replication fork progression in Werner's syndrome. Aging Cell, 1, 30-9.
38. Sakamoto, S. et al. (2001) Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51. Genes Cells, 6, 421-30.
39. Sidorova, J.M. et al. (2008) The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest. Cell Cycle, 7, 796-807.
40. Yu, C.E. et al. (1996) A YAC, P1, and cosmid contig and 17 new polymorphic markers for the Werner syndrome region at 8p12-p21. Genomics, 35, 431-40.
41. Machwe, A. et al. (2011) Molecular cooperation between the Werner syndrome protein and replication protein A in relation to replication fork blockage. J. Biol. Chem., 286, 3497-508.
42. Machwe, A. et al. (2007) Replication fork regression in vitro by the Werner syndrome protein (WRN): holliday junction formation, the effect of leading arm structure and a potential role for WRN exonuclease activity. Nucleic Acids Res., 35, 5729-47.
43. Opresko, P.L. et al. (2001) Coordinate action of the helicase and 3' to 5' exonuclease of Werner syndrome protein. J. Biol. Chem., 276, 44677-87.
44. Orren, D.K. et al. (2002) The Werner syndrome helicase/exonuclease (WRN) disrupts and degrades D-loops in vitro. Biochemistry, 41, 13483-8.
45. Osman, F. et al. (2007) Exploring the roles of Mus81-Eme1/Mms4 at perturbed replication forks. DNA Repair (Amst.), 6, 1004-17.
46. Aggarwal, M. et al. (2010) Delineation of WRN helicase function with EXO1 in the replicational stress response. DNA Repair (Amst.), 9, 765-76.
47. Froget, B. et al. (2008) Cleavage of stalled forks by fission yeast Mus81/ Eme1 in absence of DNA replication checkpoint. Mol. Biol. Cell, 19, 445-56.
48. Wechsler, T. et al. (2011) Aberrant chromosome morphology in human cells defective for Holliday junction resolution. Nature, 471, 642-6.
49. Durkin, S.G. et al. (2007) Chromosome fragile sites. Annu. Rev. Genet., 41, 169-92.
50. Glover, T.W. et al. (1984) DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet., 67, 136-42.
51. Kamath-Loeb, A.S. et al. (2001) Interactions between the Werner syndrome helicase and DNA polymerase delta specifically facilitate copying of tetraplex and hairpin structures of the d(CGG)n trinucleotide repeat sequence. J. Biol. Chem., 276, 16439-46.
52. Glover, T.W. (2006) Common fragile sites. Cancer Lett., 232, 4-12.